Clinical Trial Update: The Safety, Tolerability and Efficacy of Multiple Subcutaneous Injections of SHR-1209 in Subjects With Hyperlipidemia [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial evaluating multiple subcutaneous injections of SHR-1209 in adults with hyperlipidemia to assess safety, tolerability, and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• SHR-1209

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Hyperlipidemia | Phase 1, Phase 2 | Status: COMPLETED